Latest News about FDA
Recent news which mentions FDA
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
From Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
June 07, 2023
Tickers
HLTH
From Benzinga
FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades
June 06, 2023
Tickers
GSK
From Benzinga
Federal Psychedelics Reform Has More Lobbyists, Addiction Research Grant & Upcoming $27M VA Report
May 31, 2023
From Benzinga
From Benzinga
FDA Is Inaccurately Using Incomplete Safety Data On CBD To Refuse Regulation, Says Hemp Non-Profit
May 31, 2023
From Benzinga
FDA Presents Potential Framework For CBD, From Edibles To Delta-8, Reaffirms Congress Is In Charge
May 30, 2023
Tickers
JAZZ
From Benzinga
Numinus CEO Outlines MDMA Assisted-Therapy Strategy; Believes MAPS Phase 3 Data Coming Soon
May 26, 2023
From Benzinga
Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
May 24, 2023
Tickers
PHAT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.